Presentation is loading. Please wait.

Presentation is loading. Please wait.

PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health.

Published byDamian Hamming Modified over 10 years ago

Similar presentations

Presentation on theme: "PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health."— Presentation transcript:

1 PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health Organization

2 What is the problem? What are the causes? (the role of private health sector) What are the possible solutions? (the role of private health sector) How to approach the problem of anti-TB drug resistance

3 What is the problem? Drug susceptible TB* *or limited resistance Manageable with 4 drug regimen Cure rate: virtually 100% Resistance to H&R Treatable with 2 nd line drugs Cure rate: up to 80% MDR-TB 1990 XDR-TB 2006 Resistance to (R, H, Fqs) and (Km or Am or Cm) Treatment options seriously restricted Cure rate: up to 35%

4 Based on 138 settings surveyed in 116 countries between 1994-2007 489,000 incident cases in 2006 (95% CI: 455,000–614,000) 4.8% of all cases notified in 2006 (95% CI: 4.6%–6.0%) Global estimate of MDR-TB

5 MDR-TB among new TB cases, 1994-2007

6 XDR-TB among MDR-TB cases, 1994-2007 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.  WHO 2006. All rights reserved

7 XDR-TB in South Africa Study characteristics (53 patients)No. (%) No prior TB Treatment26 (51) Prior TB treatment Cure or Completed treatment14 (28) Treatment Default or Failure7 (14) HIV-infected (44 tested)44 (100) Dead (Includes 34% on ARV)52 (98) Identical M. tb spoligotype26/30 Lancet 2006; 368:1575-80

8 What are the causes? Role of private health sector in creation of DR-TB Drug resistance is man made -Treatment regimens prescribed by health care providers: no data on DR-TB but plenty of papers on mismanagement of TB in the private sector -Quality of drugs: absence of tender market for SLD and wider use of SLD outside NTPs -Patient's adherence to treatment: high default rates (>15%) if no patient support measures in place

9 Role of private health sector in prevention & management of DR-TB: the Makati model 1999: privately initiated Private-Public Mix DOTS (PPMD) at Makati Medical Center (MMC) DOTS Clinic 2000: Green Light Committee (GLC) Pilot project for 200 patients (MMC PPMD unit) 2003: 100% DOTS coverage in the Philippines (case detection rate: 75%, 2005; success rate: 87%, 2004) 2003: expansion of GLC Pilot to faith-based organizations; start of Round 2 GF(500 patients) 2004: decentralization of MDR services to public health centers (hospital and public health centers) 2006: “formal” mainstreaming of MDR TB management into the NTP: Round 5 GF (2,500 patients)

10 TDF-MMC DOTS Clinic (private PPMD) KASAKA Housing Facility (private) LCP DOTS Center (gov’t PPMD) Tala, Tayuman, MM South,Cebu Phases in PMDT implementation Faith-based orgs Public health centers PPMD units TDF, Philippines Pilot ExpansionMainstreaming to the NTP

11 Role of private health sector in diagnosis of DR-TB South Africa has 16 labs capable of performing culture and 14 capable of performing drug susceptibility testing (DST) All the rest of Africa has only 13 laboratories capable of performing culture and only 11 that can do DST Crucial role for private/university/research labs!

12 II Meeting of the WHO Task Force on XDR-TB 9-10 April, Geneva, Switzerland Recommendation: Countries to involve all health care providers in the global response to MDR-TB and XDR-TB

13 The way forward for PPM MDR-TB Creation of "Joint group on PPM-MDR TB" representing PPM Subgroup and MDR-TB Working Group. Possible areas of work: Assessment of the problem in key settings Documentation of best practices and models Development of framework for PPM MDR-TB based on WHO guidelines Pilot testing of PPM MDR-TB in key settings

14 Conclusions No success in TB control without success in MDR- TB and HIV control No success in MDR-TB control without involvement of all health care providers Collaborative work needed with all health care providers to: - support and improve the Global Response Plan - coordinate efforts to address all bottlenecks

15 Acknowledgments Ernesto Jaramillo Berthollet Kaboru Kitty Lambregts Mamel Quelapio Mukund Uplekar THANK YOU!

Download ppt "PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health."

Similar presentations

1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.

1 TREATMENT AND PREVENTION SCALE-UP: THE SOUTH AFRICAN EXPERIENCE By Dr Moolman Team South Africa.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.

DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
EMR Intercountry Workshop, December 2010 1 |1 | VP-IBD Surveillance Data, 2009 Photo: Dr. Mary Agócs.

EMR Intercountry Workshop, December |1 | VP-IBD Surveillance Data, 2009 Photo: Dr. Mary Agócs.
Malaria Figures 3.3 billion people at risk of malaria in 2006 1.2 billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.

Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.

MDR-TB GLOBALLY AND IN THE REGION 2013 Dr Samiha Baghdadi Medical officer – STB WHO – EMRO Cairo March 2014.
Scale-up of Programmatic MDR TB Management (PMTM) in the Philippines ROSALIND G. VIANZON, MD, MPH NTP Manager Department of Health Philippines.

Scale-up of Programmatic MDR TB Management (PMTM) in the Philippines ROSALIND G. VIANZON, MD, MPH NTP Manager Department of Health Philippines.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.

From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.

PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.

Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
What, Where, How and Action Steps… XDR-TB

What, Where, How and Action Steps… XDR-TB
Monitoring PPM contributions – from operational research to regular reporting Knut Lönnroth Stop TB Department 5 th PPM Subgroup Meeting Cairo, 4 June.

Monitoring PPM contributions – from operational research to regular reporting Knut Lönnroth Stop TB Department 5 th PPM Subgroup Meeting Cairo, 4 June.
WHO Regional Director for the Western Pacific Dr Shin Young-soo Malaria in the Pacific – Successes and Challenges.

WHO Regional Director for the Western Pacific Dr Shin Young-soo Malaria in the Pacific – Successes and Challenges.
Country Update: Tuberculosis in Thailand

Country Update: Tuberculosis in Thailand
The TB situation in the Americas: Reaching the MDGs on TB Dr. Jarbas Barbosa Area Manager, Health Surveillance & Disease Management 23 March 2007.

The TB situation in the Americas: Reaching the MDGs on TB Dr. Jarbas Barbosa Area Manager, Health Surveillance & Disease Management 23 March 2007.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.

Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Multidrug- resistant tuberculosis: update 2012. 1 Multidrug-resistant TB in the world update October 2012  WHO 2012 © World Health Organization 2012.

Multidrug- resistant tuberculosis: update Multidrug-resistant TB in the world update October 2012  WHO 2012 © World Health Organization 2012.
What, Where, How and Action Steps… XDR-TB

What, Where, How and Action Steps… XDR-TB
TITLE from VIEW and SLIDE MASTER | August 7, 2015 1 |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

Similar presentations

Ads by Google